TrialThe New England journal of medicine2024
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
Bin Cao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
64 papers cite itlatest 60 shown
this paperpooled ittrialcites it